Efficacy and safety of twice-daily treatment with canagliflozin, a sodium glucose co-transporter 2 inhibitor, added on to metformin monotherapy in patients with type 2 diabetes mel...

by Rong Qiu, MD, PhD, George Capuano, PhD, Gary Meininger, MD
Published 2014-06-01